Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in HeartMate 3 LVAD Patients
NCT04974684Completed
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Apr 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of apixaban in thrombosis, sponsored by Institute for Clinical and Experimental Medicine. Started Apr 2022; status: completed.
02
Drugs
apixaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT04974684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04974684.